S&P 500 Futures
(0.27%) 5 105.00 points
Dow Jones Futures
(0.65%) 38 631 points
Nasdaq Futures
(0.54%) 17 744 points
Oil
(0.32%) $79.20
Gas
(0.25%) $2.04
Gold
(-0.01%) $2 309.40
Silver
(-0.11%) $26.80
Platinum
(1.13%) $973.50
USD/EUR
(-0.15%) $0.931
USD/NOK
(-0.50%) $10.94
USD/GBP
(-0.21%) $0.796
USD/RUB
(0.53%) $91.62

Actualizaciones en tiempo real para Addex Therapeutics Ltd [ADXN.SW]

Bolsa: SIX Industria: Pharmaceuticals, Biotechnology & Life Sciences
Última actualización3 may 2024 @ 03:50

0.61% CHF 0.0660

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 03:50):

Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland...

Stats
Volumen de hoy 273 751
Volumen promedio 1.18M
Capitalización de mercado 5.34M
EPS CHF-0.0339 ( 2023-09-30 )
Last Dividend CHF0 ( N/A )
Next Dividend CHF0 ( N/A )
P/E -0.440
ATR14 CHF0.00100 (1.52%)

Addex Therapeutics Ltd Correlación

10 Correlaciones Más Positivas
10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Addex Therapeutics Ltd Finanzas

Annual 2022
Ingresos: CHF1.42M
Beneficio Bruto: CHF-13.20M (-928.06 %)
EPS: CHF-0.470
FY 2022
Ingresos: CHF1.42M
Beneficio Bruto: CHF-13.20M (-928.06 %)
EPS: CHF-0.470
FY 2021
Ingresos: CHF2.92M
Beneficio Bruto: CHF0.00 (0.00 %)
EPS: CHF-0.450
FY 2020
Ingresos: CHF3.61M
Beneficio Bruto: CHF0.00 (0.00 %)
EPS: CHF-0.480

Financial Reports:

No articles found.

Addex Therapeutics Ltd

Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of oral small molecule allosteric modulators of G-protein coupled receptors. Its lead programs include Dipraglurant for the treatment of Parkinson's disease levodopa-induced dyskinesia, and dystonia; ADX71149 for epilepsy and undisclosed CNS disorders; and GABAB PAM for addiction. It has license and collaboration agreement with Janssen Pharmaceuticals Inc.; Indivior PLC; and The Charcot–Marie–Tooth Association. The company was formerly known as Addex Pharmaceuticals Ltd and changed its name to Addex Therapeutics Ltd in March 2012. Addex Therapeutics Ltd was founded in 2002 and is headquartered in Geneva, Switzerland.

Acerca de Señales en Vivo

Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.

Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico